Imaging Tumor Angiogenesis Using Contrast-Enhanced Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) enhanced with contrast media has the potential to measure the level of angiogenesis in cancers and to monitor the immediate effects of drugs intended to inhibit angiogenesis. To appreciate the significance of such potential, it is necessary to first understand what is angiogenesis and why it is receiving so much attention.
KeywordsPermeability Surface Placenta Growth Factor Histologic Assay Contrast Medium Concentration Macromolecular Contrast Agent
Unable to display preview. Download preview PDF.
- 1.Folkman J (1989) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4–6Google Scholar
- 4.Fidler 1, Ellis L (1994) The implication of angiogenesis for the biology and therapy of cancer metastases. Cell 79: 185188Google Scholar
- 7.Folkman J (1992) Introduction: angiogenesis and cancer. Semin Cancer Biol 3: 47–48Google Scholar
- 13.Daldrup H, Shames D, Wendland M, et al. (1998) Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macro-molecular and small molecular contrast media. Am J Roentgen 171: 941–949Google Scholar
- Stack JP, Redmond OM, Codd MB, Dervan PA. Ennis JT (1990) Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 174: 491–494Google Scholar
- 19.Buadu L, Murakami J. Murayama S, Hashiguchi N, Masuda K, Toyoshima S (1996) Correlation between contrast-enhanced MR imaging of the breast and tumor angiogenesis: a quantitative and qualitative study. In: Annual Meeting American Roengen Ray Society. San Diego, Abstract 58Google Scholar
- 23.Spraggins T, de Paredes E, DeAngelis G (1993) Three-dimensional keyhole imaging: application to dynamic contrast-enhanced MRI of the breast. Proceedings of the Society of Magnetic Resonance in Medicine. Berkeley, Abstract 115Google Scholar